-
公开(公告)号:US20230099060A1
公开(公告)日:2023-03-30
申请号:US18057355
申请日:2022-11-21
申请人: GLYCOM A/S
摘要: It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.
-
公开(公告)号:US20220378809A1
公开(公告)日:2022-12-01
申请号:US17755956
申请日:2020-11-13
申请人: GLYCOM A/S
IPC分类号: A61K31/702 , A61K35/745 , A61K9/48 , A61K9/16 , A61P1/12
摘要: This invention relates to a method and composition for balancing the bile acid profile in the intestine of humans, particularly decreasing primary bile acids and/or increasing production of secondary bile acids.
-
公开(公告)号:US11505567B2
公开(公告)日:2022-11-22
申请号:US16630372
申请日:2018-07-12
申请人: GLYCOM A/S
摘要: It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.
-
4.
公开(公告)号:US20220267782A1
公开(公告)日:2022-08-25
申请号:US17596781
申请日:2020-06-19
申请人: Glycom A/S
发明人: Margit PEDERSEN
IPC分类号: C12N15/70 , C12N15/113
摘要: The present invention relates to the field of recombinant production of biological molecules in host cells. The invention provides nucleic acid constructs that allow to modify expression of a desired gene using both in vitro and in vivo gene expression systems with optimized stem-loop structures in the 5′ UTR of said genes. The constructs can advantageously be used to produce a variety of biological molecules recombinantly in industrial scales, e.g. human milk oligosaccharides (HMOs)
-
公开(公告)号:US11419884B2
公开(公告)日:2022-08-23
申请号:US16312506
申请日:2017-06-23
申请人: GLYCOM A/S
IPC分类号: A61K31/702 , C12P1/04 , A61P31/04 , A61K31/7016 , C07H1/00 , C12P19/04 , C12N9/10 , A61K31/716 , A61K31/7032
摘要: The present disclosure relates to synthetic mixtures of certain human milk oligosaccharides and uses thereof. Particular mixtures provided herein include: lacto-N-triose II, lacto-N-neotetraose, para-lacto-N-neohexaose, and, optionally, lactose; and lacto-N-triose II, lacto-N-tetraose, para-lacto-N-hexaose II, and, optionally, lactose. These mixtures are useful in the prevention and treatment of viral and bacterial infections.
-
公开(公告)号:US20220119437A1
公开(公告)日:2022-04-21
申请号:US17646093
申请日:2021-12-27
申请人: GLYCOM A/S
IPC分类号: C07H1/06 , B01D61/02 , B01D61/04 , B01D61/58 , B01D69/02 , B01D69/12 , B01D71/56 , B01D71/58 , C07H3/06 , C12P19/04 , C08B37/00 , C12P19/12 , A23L33/00 , C12P19/18
摘要: This invention relates to a method for the enzymatic synthesis of oligosaccharides, preferably human milk oligosaccharides (HMOs) The method comprises the enzymatic transfer of a glycosyl moiety and subsequent removal of by-products, such as lactose, by nanofiltration using a membrane comprising an active polyamide layer.
-
公开(公告)号:US11304966B2
公开(公告)日:2022-04-19
申请号:US16956511
申请日:2018-12-19
申请人: Glycom A/S
IPC分类号: A61K31/702 , A61P1/00 , A61K31/7016
摘要: The application relates to synthetic compositions and methods for preventing or reducing nociception and/or nociceptive sensitivity in a non-infant human. The human is administered a composition comprising 6′-sialyllactose (6′-SL) and/or lacto-N-tetraose (LNT).
-
公开(公告)号:US11224605B2
公开(公告)日:2022-01-18
申请号:US16303131
申请日:2017-05-19
申请人: Glycom A/S
IPC分类号: A61K31/702 , A61P1/00 , A61P25/00
摘要: The application relates to synthetic compositions containing one or more human milk oligosaccharides for treating serotonin and/or tryptophan dysregulation.
-
公开(公告)号:US11173171B2
公开(公告)日:2021-11-16
申请号:US16820126
申请日:2020-03-16
申请人: Glycom A/S
发明人: Elise Champion , Bruce McConnell , Gyula Dekany
IPC分类号: A61K31/702 , C07H3/06 , C12P19/14 , C12P19/26 , C07H1/00 , C12P19/00 , C07H5/06 , C12P19/18 , A61P31/04 , A61P31/12 , A61K31/7016
摘要: A mixture of human milk oligosaccharides that consists essentially of 3′-O-sialyllactose, a component A which is either 3-O-fucosyllactose or lacto-N-tetraose, a component B which is 3-0-fucosyl-3′-O-sialyllactose when component A is 3-O-fucosyllactose and sialyllacto-N-tetraose a, when component A is lacto-N-tetraose and optionally lactose as a fourth component. The mixtures are made by treating 3′-O-sialyllactose and component A with an α2,3-transsialidase. The mixtures are for use in anti-bacterial and anti-viral compositions, and for promoting the development of Bifidobacterium and Barnesiella.
-
公开(公告)号:US20210252028A1
公开(公告)日:2021-08-19
申请号:US17114850
申请日:2020-12-08
申请人: Glycom A/S
摘要: A method and composition including an effective amount of one or more synthetic neutral HMOs are disclosed for modulating the microbiota in the gastro-intestinal tracts of non-infant humans who are carriers of the human fucosyltransferase 2 (FUT2) genetic mutation and for improving one or more gastrointestinal conditions.
-
-
-
-
-
-
-
-
-